# Implantica publishes Interim Report January - September 2026 (Q3)

- Source: PR Newswire M&A
- Published: 2026-11-19T07:48:00+00:00
- Category: Business
- Original: https://www.prnewswire.com/news-releases/implantica-publishes-interim-report-january--september-2026-q3-302945111.html
- Canonical: https://groundlevelnews.com/story/implantica-publishes-interim-report-january-september-2026-q3-b0c97f/

VADUZ, Liechtenstein, Nov. 19, 2026 /PRNewswire/ -- FDA approval secured and first U.S. patients treated at USC Significant events in the third quarter of 2026 FDA Premarket Approval (PMA) granted for RefluxStop® on August 20, opening the world's largest medical device market and enabling...

_Ground Level News shows a short summary only; the full article and all rights belong to PR Newswire M&A._
